4DMedical Limited operates as a medical technology company in the United States and Australia. It engages in the medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging. The company also offers X-ray velocimetry lung ventilation analysis software (XV LVAS), a lung airflow imaging software, that provides lung health detail from X-Ray scans; computed tomography lung ventilation analysis software (CT LVAS), an image processing software which operates on CT scans to provide functional lung health detail; XV Scanner, a lung function scanner; and Permetium, a multi-function imaging system for pulmonary investigations. The company was incorporated in 2012 and is based in Carlton, Australia.
Metrics to compare | 4DX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4DXPeersSector | |
---|---|---|---|---|
P/E Ratio | −5.9x | −3.3x | −0.6x | |
PEG Ratio | 1.21 | −0.05 | 0.00 | |
Price/Book | 3.0x | 1.6x | 2.6x | |
Price / LTM Sales | 56.9x | 3.0x | 3.2x | |
Upside (Analyst Target) | 63.5% | 173.8% | 44.1% | |
Fair Value Upside | Unlock | 11.2% | 6.2% | Unlock |